Dr. Niklas Beschorner is a co-founder of PROVIREX. He participates in the active management of the company and focuses on process development, preclinical research and development work. He is also involved in the technical equipment of the new laboratories and clean rooms and responsible for the development of novel clinical delivery options for the recombinase technology. He studied biotechnology in Emden.
After his diploma degree in the iso-certified industry in the field of cell line development, he joined the Hauber group at the Leibniz Institute of Virology in Hamburg and became involved with the topic of delivery options for recombinase technology early on, which was also the topic of his PhD. He has now been in the field of HIV cure strategies for over 15 years.